Tuesday, 20 March 2012

Important Webinar: AVI Clinical Trial Update - PPMD Community

Important Webinar: AVI Clinical Trial Update - PPMD Community: Parent Project Muscular Dystrophy presents an AVI webinar on Wednesday, March 21 at 1pm eastern. The webinar will cover a pre-data update on AVI BioPharma's Phase IIb study evaluating eteplirsen for the treatment of Duchenne patients with mutations amenable to exon-51 skipping, and will be lead by Chris Garabedian, the CEO of AVI BioPharma.

No comments:

Post a comment